Latanoprost Sandoz

Latanoprost, the active ingredient in Latanoprost Sandoz, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It treats open-angle glaucoma and ocular hypertension by lowering intra‑ocular pressure in adult patients.

GNH USA supplies Latanoprost Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide.

Latanoprost is a prostaglandin analog used to manage conditions that involve elevated intraocular pressure.

- Open-angle glaucoma: reduces intraocular pressure to protect optic nerve health. - Ocular hypertension: lowers intraocular pressure to prevent progression to glaucoma. - Elevated intraocular pressure: helps maintain normal pressure levels and reduce risk of optic nerve damage. - Secondary open-angle glaucoma: may be used as adjunct therapy to achieve target pressure reduction.

Latanoprost may cause ocular and systemic reactions, most of which are mild and transient.

Common Side Effects: - Conjunctival hyperemia: redness of the eye. - Increased iris pigmentation: darkening of the iris color. - Periocular skin darkening: mild hyperpigmentation of the eyelid skin. - Eyelash growth: longer, thicker eyelashes. - Eye irritation or foreign‑body sensation.

Serious or Rare Side Effects: - Ocular inflammation: uveitis or iritis. - Corneal edema: swelling of the cornea. - Severe allergic reaction: eyelid swelling, itching, or rash. - Vision changes: sudden loss of visual acuity. - Persistent eye pain or discomfort.

Before prescribing Latanoprost, consider patient‑specific factors and handling requirements.

- Pregnancy: safety not established; avoid use unless clearly needed. - Breastfeeding: unknown excretion; weigh benefits against potential risks. - Pre‑existing ocular conditions: monitor for inflammation or corneal disease. - Concomitant ocular surgery: discontinue before and after procedures as advised. - Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory eye drops: may reduce efficacy of Latanoprost. - Systemic prostaglandin analogs: potential additive effects on intraocular pressure.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: may have additive pressure‑lowering effect; monitor IOP. - Carbonic anhydrase inhibitors: combined therapy may increase risk of ocular irritation.